Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases

Hiroyuki Yazu(Tsurumi University), Hiroshi Fujishima(Tsurumi University), Yasunori Sato(Keio University), Eisuke Shimizu(Keio University), Kazumi Fukagawa(Keio University)
Allergy Asthma and Clinical Immunology
February 1, 2021
Cited by 27


Related Papers